Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ITGAE - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LINC01120 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ADH5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARRB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RGMB-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDC20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDK4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GNAS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDCD5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UTP11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PHF19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TYMS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LDLRAD4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VPS29 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNX5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNORD24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TBCE - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPSM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PAGR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on